Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Endovia Health Sciences, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 16 | 18 | +2 |
| Shares | 679.9K | 1.11M | +430.7K (+63.4%) |
| Value | $243.9K | $172.1K | −$71.9K (−29.5%) |
New holders (6)
Institutions that held Endovia Health Sciences, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 348,418 | $54.0K | 0.00% |
| Compass Financial Management LLC | 64,500 | $10.0K | 0.00% |
| Point72 Asset Management, L.P. | 56,950 | $8.83K | 0.00% |
| StoneX Group Inc. | 28,151 | $5.35K | 0.00% |
| Goldman Sachs Group Inc | 20,405 | $3.16K | 0.00% |
| Harbour Investments, Inc. | 470 | $73 | 0.00% |
Sold out (4)
Institutions that held Endovia Health Sciences, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| UBS Group AG | 53,111 | $19.1K |
| Citadel Advisors LLC | 16,585 | $5.96K |
| Vanguard Global Advisers, LLC | 152 | $55 |
| Citigroup Inc | 1 | $0 |